BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1348 related articles for article (PubMed ID: 18463380)

  • 1. Tumor angiogenesis.
    Kerbel RS
    N Engl J Med; 2008 May; 358(19):2039-49. PubMed ID: 18463380
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angiogenesis under Delta-Notch couple control].
    Suchting S; Freitas C; Eichmann A
    Med Sci (Paris); 2007 Apr; 23(4):347-8. PubMed ID: 17433219
    [No Abstract]   [Full Text] [Related]  

  • 3. Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2.
    Gao W; Sweeney C; Walsh C; Rooney P; McCormick J; Veale DJ; Fearon U
    Ann Rheum Dis; 2013 Jun; 72(6):1080-8. PubMed ID: 23161900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow-derived cells: roles in solid tumor. Minireview.
    Wu XZ; Chen D; Xie GR
    Neoplasma; 2007; 54(1):1-6. PubMed ID: 17203886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor receptors: expression and function in solid tumors.
    Wey JS; Stoeltzing O; Ellis LM
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):37-45. PubMed ID: 16163158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
    Hicklin DJ; Ellis LM
    J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The function of vascular endothelial growth factor.
    Nieves BJ; D'Amore PA; Bryan BA
    Biofactors; 2009; 35(4):332-7. PubMed ID: 19415738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis.
    Funahashi Y; Hernandez SL; Das I; Ahn A; Huang J; Vorontchikhina M; Sharma A; Kanamaru E; Borisenko V; Desilva DM; Suzuki A; Wang X; Shawber CJ; Kandel JJ; Yamashiro DJ; Kitajewski J
    Cancer Res; 2008 Jun; 68(12):4727-35. PubMed ID: 18559519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor angiogenesis and its inhibitors].
    Shibuya M
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():149-53. PubMed ID: 23513829
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiogenesis regulated by VEGF and its receptors and its clinical application.
    Shibuya M
    Rinsho Ketsueki; 2009 May; 50(5):404-12. PubMed ID: 19483401
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tumor angiogenesis: recent progress and remaining challenges].
    Feige JJ
    Bull Cancer; 2010 Nov; 97(11):1305-10. PubMed ID: 21051315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis as a therapeutic target in cancer.
    Kumaran G; Clamp AR; Jayson GC
    Clin Med (Lond); 2008 Aug; 8(4):455-8. PubMed ID: 18724620
    [No Abstract]   [Full Text] [Related]  

  • 13. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The vascular endothelial growth factor (VEGF): a model of gene regulation and a marker of tumour aggressiveness. An obvious therapeutic target?].
    Grépin R; Pagès G
    J Soc Biol; 2009; 203(2):181-92. PubMed ID: 19527632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF/VEGFR signalling as a target for inhibiting angiogenesis.
    Kiselyov A; Balakin KV; Tkachenko SE
    Expert Opin Investig Drugs; 2007 Jan; 16(1):83-107. PubMed ID: 17155856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system.
    Tie J; Desai J
    Crit Rev Oncog; 2012; 17(1):51-67. PubMed ID: 22471664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenesis and vascular endothelial growth factor/vascular endothelial growth factor receptor targeting as part of a combined-modality approach to the treatment of cancer.
    O'Reilly MS
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S64-6. PubMed ID: 17848299
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of tumor growth via inhibition of tumor angiogenesis.
    Plate KH
    Adv Exp Med Biol; 1998; 451():57-61. PubMed ID: 10026850
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiogenesis as a therapeutic target.
    Ferrara N; Kerbel RS
    Nature; 2005 Dec; 438(7070):967-74. PubMed ID: 16355214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF-A and the induction of pathological angiogenesis.
    Nagy JA; Dvorak AM; Dvorak HF
    Annu Rev Pathol; 2007; 2():251-75. PubMed ID: 18039100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.